(Q41880781)

13 October 2017

Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics (English)

1 reference

ORCID Public Data File 2021

13 October 2017

hepatic insufficiency

1 reference

1 reference

1 reference

1 reference

1 reference

author name string

Marian Iwamoto

1

1 reference

13 October 2017

William D Hanley

2

1 reference

13 October 2017

Amelia S Petry

3

1 reference

13 October 2017

Evan J Friedman

4

1 reference

13 October 2017

James T Kost

5

1 reference

13 October 2017

Sheila A Breidinger

6

1 reference

13 October 2017

Kenneth C Lasseter

7

1 reference

13 October 2017

Richard Robson

8

1 reference

13 October 2017

Norman M Lunde

9

1 reference

13 October 2017

Larissa A Wenning

10

1 reference

13 October 2017

Julie A Stone

11

1 reference

13 October 2017

John A Wagner

12

1 reference

13 October 2017

language of work or name

English

0 references

publication date

17 February 2009

1 reference

13 October 2017

6

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

13 October 2017

53

1 reference

13 October 2017

5

1 reference

13 October 2017

1747-1752

1 reference

Ways to fit a PK model with some data below the quantification limit

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Transection of the oesophagus for bleeding oesophageal varices

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Is glucuronidation truly preserved in patients with liver disease?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Effects of omeprazole on plasma levels of raltegravir

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681501

Influence of range of renal function and liver disease on predictability of creatinine clearance

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19223645

12 December 2020

inferred from PubMed ID database lookup

Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MS

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19223645

12 December 2020

inferred from PubMed ID database lookup

Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19223645

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.01194-08

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

19223645

1 reference